COMMUNIQUÉS West-GlobeNewswire

Symposium and Panel Discussion on Nymox's Fexapotide To Be Held at American Urological Association Mid-Atlantic Section Annual Meeting on March 3

01/03/2018 - 15:30

HASBROUCK HEIGHTS, N.J., March 01, 2018 (GLOBE NEWSWIRE) -- Nymox Pharmaceutical Corporation (NASDAQ: NYMX ) is pleased to report that a Symposium on Fexapotide Triflutate studies will be held at the Annual Meeting of [...]

Cellular Biomedicine Group Invited to Present a Keynote Speech at Phar-East Asia Pharma & Biotech Festival

01/03/2018 - 15:15

SHANGHAI, China and CUPERTINO, Calif., March 01, 2018 (GLOBE NEWSWIRE) -- Cellular Biomedicine Group Inc. (NASDAQ: CBMG ) (“CBMG” or the “Company”), a biomedicine firm engaged in the development of effective [...]

Sensoria Health Brings Personal, Data-Driven, Interoperable and Reliable Microsoft Azure IoT platform Architecture to Healthcare

01/03/2018 - 15:07

LAS VEGAS, March 01, 2018 (GLOBE NEWSWIRE) -- Technology is a key enabler in the precision medicine trend, which will transform healthcare in the next few years. However, improving outcomes while reducing cost is a [...]

TrustedHealth Announces March Token Sale to Increase Global Access to World’s Leading Medical Specialists Through the Blockchain

01/03/2018 - 15:04

NEW YORK, March 01, 2018 (GLOBE NEWSWIRE) -- TrustedHealth , a blockchain-based patient and doctor-centric health ecosystem in specialized medicine, today announces the launch of its March token sale. The company is [...]

Cohera Medical, Inc.® submits PMA Supplement to expand indications for TissuGlu® Surgical Adhesive

01/03/2018 - 15:00

RALEIGH, N.C., March 01, 2018 (GLOBE NEWSWIRE) -- Cohera Medical, Inc., a leading innovator and developer of absorbable surgical adhesives and sealants, announced today that it has submitted a Premarket Approval [...]

Coherus BioSciences Management to Present at Two Investor Healthcare Conferences in March

01/03/2018 - 15:00

REDWOOD CITY, Calif., March 01, 2018 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (Nasdaq: CHRS ) today announced that senior management will present at two upcoming investor healthcare conferences. Management [...]

Oxford Immunotec Announces Appointment of Mark Klausner to the Board of Directors

01/03/2018 - 15:00

OXFORD, United Kingdom and MARLBOROUGH, Mass., March 01, 2018 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq: OXFD ), a global, high-growth diagnostics company, today announced the appointment of Mark Klausner [...]

Breathtec Biomedical Announces Appointment of CEO

01/03/2018 - 15:00

VANCOUVER, British Columbia, March 01, 2018 (GLOBE NEWSWIRE) -- Breathtec Biomedical Inc. (CSE:BTH) (CNSX: BTH ) (FRANKFURT: BTI ) (OTCQB:BTHCF) (the “Company”) is pleased to announce the appointment of Christopher J. [...]

Integrated Healthcare Association (IHA) Releases 2nd Edition of the California Regional Health Care Cost & Quality Atlas

01/03/2018 - 15:00

OAKLAND, Calif., March 01, 2018 (GLOBE NEWSWIRE) -- Health care quality and cost for commercially insured Californians varied dramatically in 2015, indicating that where you live affects the care you receive and how [...]

Alphatec Holdings to Report Fourth Quarter and Fiscal Year 2017 Financial Results on March 8, 2018

01/03/2018 - 15:00

CARLSBAD, Calif., March 01, 2018 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq: ATEC ) (the “Company”), the parent company of Alphatec Spine, Inc., a provider of spinal fusion technologies, announced today that [...]

INSYS Therapeutics Confirms Completion of Founder’s Independent Trust

01/03/2018 - 15:00

PHOENIX, March 01, 2018 (GLOBE NEWSWIRE) -- INSYS Therapeutics, Inc. (NASDAQ: INSY), a leader in the development, manufacture and commercialization of pharmaceutical cannabinoids and spray technology, today announced [...]

Helsinn Healthcare S.A.: Eleven finalists have been chosen for the first ever Lyfebulb-Helsinn Innovation Summit & Award in Oncology

01/03/2018 - 14:36

Eleven finalists have been chosen for the first ever Lyfebulb-Helsinn Innovation Summit & Award in Oncology Eleven finalists have been selected from a strong roster of talent to compete at the inaugural Lyfebulb - [...]

Corium Prices Offering of $100 Million of 5% Convertible Senior Notes

01/03/2018 - 14:35

MENLO PARK, Calif., March 01, 2018 (GLOBE NEWSWIRE) -- Corium International, Inc. (Nasdaq: CORI ), a commercial-stage biopharmaceutical company focused on the development, manufacture and commercialization of specialty [...]

GTX Corp Launches $99.00 Easy Start Plan for GPS SmartSole® and Economy Service Plan as low as $14.95

01/03/2018 - 14:30

LOS ANGELES, March 01, 2018 (GLOBE NEWSWIRE) -- GTX Corp Launches $99.00 Easy Start Plan for GPS SmartSole ® and Economy Service Plan as low as $14.95 3 new pricing models for GPS SmartSole ® and Smart Locator [...]

BriaCell To Present at Precision Breast Cancer Conference

01/03/2018 - 14:30

BERKELEY, Calif. and VANCOUVER, British Columbia, March 01, 2018 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. ("BriaCell") (TSX-V: BCT ) (OTCQB:BCTXF), an immuno-oncology focused biotechnology company with a [...]

Histogenics Corporation to Report 2017 Financial Results on March 15, 2018

01/03/2018 - 14:30

WALTHAM, Mass., March 01, 2018 (GLOBE NEWSWIRE) -- Histogenics Corporation (Nasdaq: HSGX ), a leader in the development of restorative cell therapies that may offer rapid-onset pain relief and restored function, [...]

ChemoCentryx to Hold Fourth Quarter 2017 Financial Results Conference Call on Friday, March 9, 2018

01/03/2018 - 14:30

MOUNTAIN VIEW, Calif., March 01, 2018 (GLOBE NEWSWIRE) -- ChemoCentryx, Inc., (Nasdaq: CCXI ), today announced that the Company's fourth quarter 2017 financial results will be released before market open on Friday, [...]

Wildflower Quarterly Revenues Increase to $748,771

01/03/2018 - 14:30

VANCOUVER, British Columbia, March 01, 2018 (GLOBE NEWSWIRE) -- Wildflower Marijuana Inc. (CSE:SUN) (the " Company ") is pleased to announce quarterly revenues climbed from $103,893 to $748,771. The Company experienced [...]

Catalyst Biosciences Reports Fourth Quarter and Full-Year 2017 Operating & Financial Results and Provides Corporate Update

01/03/2018 - 14:30

Cash Balance in excess of $135 million after our February 2018 follow-on financing allows for independent development of lead programs Positive Phase 1/2 Subcutaneous data for CB 2679d presented at EAHAD 2018, Phase 2b [...]